Mabthera and white blood cell count decreased Patient Reports February 12, 2012

Mabthera Side Effects Report #5271872-6
Mabthera side effect was reported by a Consumer or non-health professional from FRANCE on Mar 06, 2007. Female patient, 64 years of age, weighting 132.3 lb, was diagnosed with t-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, lung disorder, lymphocyte percentage decreased, neutropenia, neutrophil percentage decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5774656-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 30, 2008. Female patient, 30 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: fatigue, musculoskeletal stiffness, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IMURAN, CORTICOIDS NOS, ANTIHISTAMINE NOS, ACETAMINOPHEN. Patient recovered.

Mabthera Side Effects Report #5782556-X
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 10, 2008. Female patient, 30 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: fatigue, musculoskeletal stiffness, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IMURAN, CORTICOIDS NOS, ANTIHISTAMINE NOS, ACETAMINOPHEN. Patient recovered.

Mabthera Side Effects Report #5805189-5
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 25, 2008. Female patient, 30 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: fatigue, musculoskeletal stiffness, pneumonitis, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IMURAN, CORTICOIDS NOS, ANTIHISTAMINE NOS, ACETAMINOPHEN. Patient recovered.


Mabthera Side Effects Report #5033782-9
Mabthera side effect was reported by a Physician from FRANCE on June 07, 2006. Female patient, 32 years of age, weighting 121.3 lb, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, paranoia, protein total decreased, psychotic disorder , pyrexia, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CORTICOID. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4625799-0
Mabthera side effect was reported by a Physician from on Mar 18, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4704615-2
Mabthera side effect was reported by a Health Professional from on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4712847-2
Mabthera side effect was reported by a Physician from AUSTRALIA on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5595008-7
Mabthera side effect was reported by a Physician from JAPAN on Jan 09, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , septic shock, urinary tract infection , white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE. Patient died on 04/28/2007.


Mabthera Side Effects Report #5632647-9
Mabthera side effect was reported by a Physician from JAPAN on Feb 12, 2008. Female patient, 76 years of age, weighting 97.66 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , septic shock, urinary tract infection , white blood cell count decreased. Mabthera dosage: 530 MG, UNK. During the same period patient was treated with IFOSFAMIDE, CISPLATIN, ETOPOSIDE, MANNITOL. Patient died on 04/28/2007.

Mabthera Side Effects Report #4932240-7
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Feb 15, 2006. Male patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Mabthera dosage: 250 MG/M2, INTRAVENOUS. During the same period patient was treated with ZEVALIN, CLADRIBINE, MITOXANTRONE. Patient recovered.

Mabthera Side Effects Report #5091713-X
Mabthera side effect was reported by a Physician from SWEDEN on Aug 16, 2006. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4772999-5
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Sept 06, 2005. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, BLOPRESS, ADONA, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, MUCOSTA, HICEE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4905311-9
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2006. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, petechiae, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, BLOPRESS, ADONA, MUCOSTA, HICEE, CIPROXIN. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4724089-5
Mabthera side effect was reported by a Health Professional from JAPAN on July 12, 2005. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 354 MG, INTRAVENOUS. During the same period patient was treated with ZEVALIN, TIMOLOL MALEATE, XALATAN, FLUMETHOLON, AMOBAN, CHLOR. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4724149-9
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on July 12, 2005. Female patient, 55 years of age, weighting 101.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow depression, neutrophil percentage decreased, neutrophil percentage increased, white blood cell count decreased. Mabthera dosage: 341 MG, INTRAVENOUS. During the same period patient was treated with ZEVALIN, BASEN, GLYBURIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4890064-3
Mabthera side effect was reported by a Physician from JAPAN on Jan 06, 2006. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, neutrophil count decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 354 MG, INTRAVENOUS. During the same period patient was treated with ZEVALIN, TIMOLOL MALEATE, XALATAN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4905350-8
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Jan 24, 2006. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 250 MG, INTRAVENOUS. During the same period patient was treated with YTTRIUM, INDIUM. Patient recovered.

Mabthera Side Effects Report #5228374-2
Mabthera side effect was reported by a Physician from CANADA on Jan 27, 2007. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic cirrhosis, hepatic steatosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.


Mabthera Side Effects Report #5162050-X
Mabthera side effect was reported by a Physician from CANADA on Nov 10, 2006. Female patient, 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic steatosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #4920113-5
Mabthera side effect was reported by a Physician from GERMANY on Feb 06, 2006. Female patient, 43 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, c-reactive protein increased, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOSORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4685147-7
Mabthera side effect was reported by a Physician from on May 25, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4708950-3
Mabthera side effect was reported by a Physician from NORWAY on June 29, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4754430-9
Mabthera side effect was reported by a Physician from NORWAY on Aug 17, 2005. Female patient, 41 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4564070-2
Mabthera side effect was reported by a Physician from on Jan 14, 2005. Female patient, 26 years of age, weighting 99.21 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, haematotoxicity, haemoglobin decreased, platelet count decreased, skin toxicity, white blood cell count decreased. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, ADRIABLASTINE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5156804-3
Mabthera side effect was reported by a Physician from CANADA on Nov 01, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic cirrhosis, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #4940898-1
Mabthera side effect was reported by a Physician from FRANCE on Feb 22, 2006. Male patient, 75 years of age, was diagnosed with lymphoproliferative disorder and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, depression , febrile bone marrow aplasia, neuropathy peripheral, neutropenia, weight decreased, white blood cell count decreased. Mabthera dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with ETOPOPHOS, ENDOXAN, PREDNISONE, DOXORUBICIN, METHOTREXATE, ONCOVIN, NEORAL, SOLUPRED. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4553507-0
Mabthera side effect was reported by a Health Professional from on Dec 29, 2004. Female patient, 73 years of age, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: neutropenia, white blood cell count decreased. Mabthera dosage: 685 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4750039-1
Mabthera side effect was reported by a Physician from FRANCE on Aug 09, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, CORTANCYL, ADRIABLASTINE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4754791-0
Mabthera side effect was reported by a Physician from FRANCE on Aug 16, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISONE, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5048834-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on June 26, 2006. Female patient, 47 years of age, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypoxia, international normalised ratio increased, lung consolidation, pneumonia , white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUCONAZOLE, ACYCLOVIR, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 03/04/2005.

Mabthera Side Effects Report #4569734-2
Mabthera side effect was reported by a Physician from on Jan 18, 2005. Male patient, 37 years of age, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bacteria urine identified, c-reactive protein increased, febrile neutropenia, white blood cell count decreased. Mabthera dosage: 800 MG Q3W INTRAVENOUS. During the same period patient was treated with ROFERON, ACETAMINOPHEN, SUMATRIPTAN SUCCINATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5122741-3
Mabthera side effect was reported by a Physician from GERMANY on Sept 26, 2006. Female patient, weighting 143.3 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: candidiasis, haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: 645 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 08/28/2006.

Mabthera Side Effects Report #5809404-3
Mabthera side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 02, 2008. Female patient, 30 years of age, was diagnosed with lupus nephritis, systemic lupus erythematosus and was treated with Mabthera. After drug was administered, patient experienced the following side effects: fatigue, interstitial lung disease, musculoskeletal stiffness, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IMURAN, CORTICOIDS NOS, ANTIHISTAMINE NOS, ACETAMINOPHEN, PREDNISONE, MICARDIS HCT, NORVASC. Patient recovered.


Mabthera Side Effects Report #5281330-0
Mabthera side effect was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.

Mabthera Side Effects Report #4649841-6
Mabthera side effect was reported by a Physician from on Apr 18, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, haemoglobin decreased, humerus fracture, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4776604-3
Mabthera side effect was reported by a Health Professional from SWITZERLAND on Sept 05, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, infection , laboratory test interference, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4569737-8
Mabthera side effect was reported by a Consumer or non-health professional from on Jan 18, 2005. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematotoxicity, haemoglobin decreased, thrombocytopenia, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4597204-4
Mabthera side effect was reported by a Consumer or non-health professional from on Feb 17, 2005. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematotoxicity, haemoglobin decreased, thrombocytopenia, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE, FILGRASTIM, FRAXIPARINE, ITRACONAZOLUM, AMOXICILLIN. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4669465-4
Mabthera side effect was reported by a Physician from on May 06, 2005. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, urinary tract infection , white blood cell count decreased. Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4716478-X
Mabthera side effect was reported by a Physician from AUSTRIA on July 05, 2005. Male patient, 72 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, ENOXAPARIN, SIMVASTATIN, ALLOPURINOL, ACETYLCYSTEINE, CARVEDILOL, ACEMIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5118564-1
Mabthera side effect was reported by a Physician from GERMANY on Sept 13, 2006. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia, c-reactive protein increased, pyrexia, white blood cell count decreased. Mabthera dosage: 860 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5047231-8
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 16, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055325-6
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, virus urine test positive, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5085560-2
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4865822-1
Mabthera side effect was reported by a Physician from FRANCE on Dec 08, 2005. Male patient, 59 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Mabthera dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with ADRIABLASTINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #5132415-0
Mabthera side effect was reported by a Consumer or non-health professional from GERMANY on Oct 04, 2006. Female patient, 58 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: gingival infection, neutropenia, oral infection, white blood cell count decreased. Mabthera dosage: 350 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, STEROIDS, PRAZOLE. Patient recovered.

Mabthera Side Effects Report #5084871-4
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 04, 2006. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, electrocardiogram t wave inversion, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphadenopathy, white blood cell count decreased. Mabthera dosage: 375MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4801537-3
Mabthera side effect was reported by a Physician from BELGIUM on Oct 03, 2005. Male patient, 52 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, rash morbilliform, white blood cell count decreased. Mabthera dosage: 975 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM DS. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4749186-X
Mabthera side effect was reported by a Health Professional from ISRAEL on Feb 24, 2005. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, parotitis, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #4685239-2
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816221-X
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816222-1
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 700 MG. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5717785-4
Mabthera side effect was reported by a Physician from UNITED KINGDOM on Apr 15, 2008. Female patient, 51 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, petechiae, thrombocytopenia, white blood cell count decreased. Mabthera dosage: 700 MG, UNK. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5106962-1
Mabthera side effect was reported by a Physician from SPAIN on Sept 04, 2006. Female patient, 28 years of age, was diagnosed with arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: inflammation, neutropenia, pyrexia, vomiting, weight decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4716473-0
Mabthera side effect was reported by a Physician from DENMARK on July 01, 2005. Female patient, 82 years of age, weighting 121.3 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, immune system disorder, white blood cell count decreased. Mabthera dosage: 585 MG, 1/WEEKX4, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, LANSOPRAZOLE, WARFARIN, EMCONCOR, MAGNYL, IMOZOP, PRIMPERAN ELIXIR, TAZOCIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4897058-2
Mabthera side effect was reported by a Consumer or non-health professional from POLAND on Jan 17, 2006. Female patient, 80 years of age, weighting 143.3 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, condition aggravated, platelet count decreased, pneumonia , shock, white blood cell count decreased. Mabthera dosage: 600 MG, QD, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4874985-3
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Dec 19, 2005. Female patient, 72 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, NEULASTA. Patient recovered.

Mabthera Side Effects Report #4928204-X
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Feb 13, 2006. Female patient, 72 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PEGFILGRASTIM, PREDNISONE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4803696-5
Mabthera side effect was reported by a Health Professional from FRANCE on Oct 04, 2005. Female patient, 50 years of age, weighting 165.3 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, eosinophil count decreased, white blood cell count decreased. Mabthera dosage: 3 MG, QD, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, VEPESID, ARACYTINE, KYTRIL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4837382-2
Mabthera side effect was reported by a Consumer or non-health professional from FRANCE on Nov 10, 2005. Female patient, 13 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, eosinophil count increased, monocyte count increased, white blood cell count decreased. Mabthera dosage: 375 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.